Design and synthesis of m1-selective muscarinic agonists:: (R)-(-)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-(3′-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist

被引:30
作者
Tecle, H [1 ]
Barrett, SD
Lauffer, DJ
Augelli-Szafran, C
Brann, MR
Callahan, MJ
Caprathe, BW
Davis, RE
Doyle, PD
Eubanks, D
Lipiniski, W
Mirzadegan, T
Moos, WH
Moreland, DW
Nelson, CB
Pavia, MR
Raby, C
Schwarz, RD
Spencer, CJ
Thomas, AJ
Jaen, JC
机构
[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48106 USA
[2] Receptor Technol Inc, Winooski, VT 05404 USA
关键词
D O I
10.1021/jm960683m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and SAR of a series of (Z)-(+/-)-1-azabicyclo[2.2. 1]heptan-3-one, O-(3-aryl-2-propynyl)oximes are described. The biochemistry and pharmacology of 24Z (PD 142505) and its enantiomers are highlighted. 24Z is functionally an mi-selective muscarinic agonist. Efficacy and mi selectivity reside in the R enantiomer, (R)-24Z (CI-1017).
引用
收藏
页码:2524 / 2536
页数:13
相关论文
共 56 条
[21]   ENANTIOSPECIFIC SYNTHESIS OF THE (4R)-1-AZABICYCLO[2.2.1]HEPTANE RING-SYSTEM [J].
HOUGHTON, PG ;
HUMPHREY, GR ;
KENNEDY, DJ ;
ROBERTS, DC ;
WRIGHT, SHB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1993, (13) :1421-1424
[22]   MUSCARINIC RECEPTOR SUBTYPES [J].
HULME, EC ;
BIRDSALL, NJM ;
BUCKLEY, NJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 :633-673
[23]   IN-VITRO AND IN-VIVO EVALUATION OF THE SUBTYPE-SELECTIVE MUSCARINIC AGONIST PD-151832 [J].
JAEN, J ;
BARRETT, S ;
BRANN, M ;
CALLAHAN, M ;
DAVIS, R ;
DOYLE, P ;
EUBANKS, D ;
LAUFFER, D ;
LAUFFER, L ;
LIPINSKI, W ;
MORELAND, D ;
NELSON, C ;
RABY, C ;
SCHWARZ, R ;
SPENCER, C ;
TECLE, H .
LIFE SCIENCES, 1995, 56 (11-12) :845-852
[24]   SUBSTITUENT VARIATION IN AZABICYCLIC TRIAZOLE-BASED AND TETRAZOLE-BASED MUSCARINIC RECEPTOR LIGANDS [J].
JENKINS, SM ;
WADSWORTH, HJ ;
BROMIDGE, S ;
ORLEK, BS ;
WYMAN, PA ;
RILEY, GJ ;
HAWKINS, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (13) :2392-2406
[25]  
JONES SVP, 1992, MOL BIOL G PROTEIN C, P170
[26]  
KUMAR V, 1991, INT J CLIN PHARM TH, V29, P23
[27]   IMMUNOLOGICAL LOCALIZATION OF M1-M5 MUSCARINIC ACETYLCHOLINE-RECEPTORS IN PERIPHERAL-TISSUES AND BRAIN [J].
LEVEY, AI .
LIFE SCIENCES, 1993, 52 (5-6) :441-448
[28]   SYNTHESIS OF AZANORBORNYL-SPIRODIOXOLANES RELATED TO THE MUSCARINIC AGONIST AF30 [J].
MACLEOD, AM ;
BAKER, R ;
HERBERT, R ;
LEWIS, RT ;
MEDARDE, M ;
STREET, LJ .
TETRAHEDRON LETTERS, 1992, 33 (29) :4217-4220
[29]   THE CYTOSENSOR MICROPHYSIOMETER - BIOLOGICAL APPLICATIONS OF SILICON TECHNOLOGY [J].
MCCONNELL, HM ;
OWICKI, JC ;
PARCE, JW ;
MILLER, DL ;
BAXTER, GT ;
WADA, HG ;
PITCHFORD, S .
SCIENCE, 1992, 257 (5078) :1906-1912
[30]   NO RESPONSE TO HIGH-DOSE MUSCARINIC AGONIST THERAPY IN ALZHEIMERS-DISEASE [J].
MOURADIAN, MM ;
MOHR, E ;
WILLIAMS, JA ;
CHASE, TN .
NEUROLOGY, 1988, 38 (04) :606-608